Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


So Long, Safe Harbor: Pay-for-Delay Riskier After Supreme Court Opinion

This article was originally published in RPM Report

Executive Summary

The Supreme Court’s majority opinion in Federal Trade Commission v. Actavis makes it easier for FTC and private plaintiffs to challenge reverse payment settlements between branded drug companies and their would-be generic competitors. While the opinion declines to find “pay-for-delay” deals presumptively anticompetitive (a win for industry), it also strips a safe harbor used by the appeals courts (a clear loss).


Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts